Copper (64Cu) Chloride

5 trials 1 recruiting VVarious

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

1 Completed trials

4 Sponsors

4 Countries

Phase III

Phase II

Phase I (FiH)

Phase III: 3 Phase II: 1 Phase I (FiH): 1

Indications tested

Prostate cancer metastatic 2 Prostate cancer 2 Neuroendocrine tumour 1

Sponsors using this IMP

A.C.O.M. Advanced Center Oncology Macerata S.r.l. 2 Region Midtjylland 1 Vivet Therapeutics 1 Voxel S.A. 1

All trials

5 total

A clinical study using a radioactive imaging agent with PET-CT to detect neuroendocrine tumors Not authorised

2025-524050-34-01 Phase III 1 country Voxel S.A.
64CuCl2 PET/CT VS 18F-choline PET/CT in prostate cancer Pending

2025-520861-29-00 Phase III 1 country A.C.O.M. Advanced Center Oncology Macerata S.r.l.
Use of the diagnostic PET with 64CuCl2 in order to select patients, in which a disease relapse is shown after prostate surgical removal, to … Pending

2025-520868-17-00 Phase III 1 country A.C.O.M. Advanced Center Oncology Macerata S.r.l.
COMPARISON OF ZINC ACETATE DOSE REGIMENS (GALZIN VS. ET-700) FOR THE TREATMENT OF WILSON DISEASE: A PHARMACODYNAMIC 64CUCL2 PET/CT STUDY IN … Recruiting

2025-523372-24-00 Phase II 1 country Region Midtjylland
Treatment of adult Wilson's Disease patients with gene therapy Ended

2023-509998-23-00 Phase I (FiH) 2 countries Vivet Therapeutics

Showing 1–5 of 5 trials

← All drugs A–Z